Robin Shane Readnour - Mar 29, 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role: Director
Signature: /s/ Lucy Day, Attorney-in-Fact for Robin Shane Readnour
Stock symbol: ANTX
Transactions as of: Mar 29, 2022
Transactions value $: $2,300,010
Form type: 4
Date filed: 3/31/2022, 08:15 PM
Previous filing: Mar 24, 2022
Next filing: May 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANTX	Common Stock	Conversion of derivative security		+285K			285K	Mar 29, 2022	See footnotes	F1, F2, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+333K			333K	Mar 29, 2022	See footnotes	F1, F3, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+61.5K	+21.56%		347K	Mar 29, 2022	See footnotes	F1, F2, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+71.8K	+21.56%		405K	Mar 29, 2022	See footnotes	F1, F3, F4
transaction	ANTX	Common Stock	Purchase	$1.06M	+70.7K	+20.4%	$15.00	417K	Mar 29, 2022	See footnotes	F2, F4
transaction	ANTX	Common Stock	Purchase	$1.24M	+82.6K	+20.4%	$15.00	488K	Mar 29, 2022	See footnotes	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANTX	Series A Convertible Preferred Stock	Conversion of derivative security	$0	-285K	-100%	$0.00^*	0	Mar 29, 2022	Common Stock	285K		See footnotes	F1, F2, F4
transaction	ANTX	Series A Convertible Preferred Stock	Conversion of derivative security	$0	-333K	-100%	$0.00^*	0	Mar 29, 2022	Common Stock	333K		See footnotes	F1, F3, F4
transaction	ANTX	Series B Convertible Preferred Stock	Conversion of derivative security	$0	-61.5K	-100%	$0.00^*	0	Mar 29, 2022	Common Stock	61.5K		See footnotes	F1, F2, F4
transaction	ANTX	Series B Convertible Preferred Stock	Conversion of derivative security	$0	-71.8K	-100%	$0.00^*	0	Mar 29, 2022	Common Stock	71.8K		See footnotes	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
F2	Shares held directly by MGC Venture Partners 2018, LP. ("MGC 2018 LP").
F3	Shares held directly by MGC Venture Partners QP 2018 LP ("MGC 2018 QP").
F4	MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP. MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.